Skip to content

A study on effect of oral tolvaptan tablet, which causes free water excretion and increases serum sodium level, to prevent hyponatremia in patients undergoing TURP surgeries.

Use of oral Tolvaptan tablet as a pre-medicant to prevent hyponatremia in patients undergoing TURP surgeries: A prospective Comparative study. - Tolvaptan in TURP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018808
Enrollment
180
Registered
2019-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: Tablet Tolvaptan 15 mg: Tablet Tolvaptan 15 mg, as a single oral dose, will be given to eligible patients undergoing TURP surgeries, 3 hours prior to the surgery. Intervention2: Tablet

Sponsors

Dr Badri Prasad Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All adult patients aged 50-75 yrs with good functional status with METS >4,with diagnosis of BPH posted for TURP surgery. 2.Prostate size >60 gms. 3.Surgeries done under monopolar cautery ( M-TURP) and irrigation fluid of 1.5% glycine. 4.Baseline serum sodium level less than or equal to 132meq/lit.

Exclusion criteria

Exclusion criteria: 1.Patients with history of allergy to study drugs. 2.Uncontrolled diabetes mellitus and hypertension 3.H/O Acute MI, any cardiac conditions,EF 4.Patients with cerebro vascular diseases, renal diseases and any other endocrine disorders like SIADH causing electrolyte imbalances. 5.C/I for subarachnoid block 7.Prostate surgery lasting less than 30 mins and more than 2 hrs

Design outcomes

Primary

MeasureTime frame
Incidence of HyponatremiaTimepoint: Serum and Urine samples for sodium and osmolarity values, will be taken at atleast 3 points of time, beforte start of therapy (Baseline), preoperativeley (at 3rd hour of giving the drug) and post-operatively at 1st hour after the patient is brought to Post-Anaesthesia-Care Unit. And at anytime as and when required.

Secondary

MeasureTime frame
Any side effects, use of hypertonic saline as a rescue for sympotamatic hyponatremia, cost-effectivenessTimepoint: Patients will be observed for atleast 2 days post-operatively, or more if required.

Countries

India

Contacts

Public ContactDr G UMA KANTHAN

IMS BHU

badriprasad.dash5@gmail.com9415214623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026